10岁及以下儿童与10岁以上儿童/成人慢性移植物抗宿主病风险生物标志物研究
该前瞻性研究纳入318例异基因造血细胞移植患者(≤10岁儿童129例,>10岁儿童/成人189例),于移植后100天检测6种血浆生物标志物,按年龄分层并以Youden指数二分法分析慢性移植物抗宿主病(cGVHD)风险。IL1RL1和DKK3在两个年龄组均与未来cGVHD相关;CXCL9、REG3α和MMP3仅在>10岁组与cGVHD相关。5标志物组合对cGVHD的AUC在≤10岁组为0.71、>10岁组为0.72,对中重度cGVHD的AUC分别为0.86和0.80;5标志物组合(IL1RL1、REG3α、MMP3、DKK3、sCD163)在两个年龄组均与移植相关死亡率(TRM)相关。
要点
- 移植后100天IL1RL1和DKK3在≤10岁与>10岁组均与未来cGVHD相关。
- CXCL9、REG3α和MMP3仅在>10岁组与cGVHD相关。
- 5标志物组合对中重度cGVHD的AUC在≤10岁组为0.86、>10岁组为0.80。
核心结论
- 移植后3个月检测的生物标志物可预测≤10岁儿童及>10岁儿童/成人cGVHD易感性及/或预后,并有助于进一步风险分层。
研究设计与样本
- 前瞻性研究,纳入318例异基因造血细胞移植患者,其中≤10岁儿童129例,>10岁儿童/成人189例。
- 于移植后100天检测6种血浆生物标志物(CXCL9、IL1RL1、REG3α、MMP3、DKK3、sCD163),按年龄≤10岁 vs >10岁分层,并以Youden指数二分法分析。
主要发现
- IL1RL1和DKK3在两个年龄组均与未来cGVHD相关。
- CXCL9、REG3α和MMP3在>10岁患者中与cGVHD相关。
- 5标志物组合对cGVHD风险的AUC在≤10岁儿童为0.71,在>10岁儿童/成人为0.72。
- 5标志物组合对中重度cGVHD风险的AUC在≤10岁儿童为0.86,在>10岁儿童/成人为0.80。
- 5标志物组合(IL1RL1、REG3α、MMP3、DKK3、sCD163)在两个年龄组均与移植相关死亡率(TRM)相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Assessment of risk biomarkers of chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic cell transplantation (HCT) in pediatric patients is lacking. We conducted a prospective study of 318 patients (129 children aged ≤10 years and 189 children/adults aged >10 years). Six plasma biomarkers (C-X-C motif chemokine ligand 9 [CXCL9], interleukin-1 receptor-like 1 [IL1RL1], regenerating islet-derived 3-α [REG3α], matrix metallopeptidase-3 [MMP3], dickkopf-WNT signaling pathway inhibitor-3 [DKK3], and sCD163) were assessed at day 100 after HCT. We performed day-100 landmark analyses for cGVHD, stratifying at age ≤10 years vs >10 years and dichotomizing markers using the Youden index. IL1RL1 associated with future cGVHD in both age groups, as did DKK3. CXCL9, REG3α, and MMP3 are associated with cGVHD in patients aged >10 years. This 5-marker panel has an area under the curve (AUC) of 0.71 in children aged ≤10 years and 0.72 in children/adults aged >10 years for cGVHD risk, and an AUC of 0.86 in children aged ≤10 years and 0.80 in children/adults aged >10 years for moderate/severe cGVHD risk. A 5-biomarker panel (IL1RL1, REG3α, MMP3, DKK3, and sCD163) was associated with transplant-related mortality (TRM) in both age groups. Biomarkers measured 3 months post-HCT predict susceptibility and/or are prognostic for cGVHD and TRM in both children aged ≤10 years and children/adults aged >10 years, allowing for additional risk stratification.
引用
- Ferreira AC, Dutta D, Rowan CM, et al. Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 years. Blood Adv. 2026. PMID: 40966416. doi:10.1182/bloodadvances.2025016624
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。